MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers
Sign Up to like & getrecommendations! Published in 2022 at "Heart Failure Reviews"
DOI: 10.1007/s10741-022-10231-z
Abstract: Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and is characterized by increased left ventricular wall thickness, but existing diagnostic and treatment approaches face limitations. MicroRNAs (miRNAs) are type of noncoding RNA molecule that… read more here.
Keywords: hypertrophic cardiomyopathy; cardiomyopathy pathogenesis; treatment; pathogenesis diagnosis ... See more keywords